Abstract
Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in Europe and North America1,2. During infection, C. difficile produces two key virulence determinants, toxin A and toxin B. Experiments with purified toxins have indicated that toxin A alone is able to evoke the symptoms of C. difficile infection, but toxin B is unable to do so unless it is mixed with toxin A or there is prior damage to the gut mucosa3. However, a recent study indicated that toxin B is essential for C. difficile virulence and that a strain producing toxin A alone was avirulent4. This creates a paradox over the individual importance of toxin A and toxin B. Here we show that isogenic mutants of C. difficile producing either toxin A or toxin B alone can cause fulminant disease in the hamster model of infection. By using a gene knockout system5,6 to inactivate the toxin genes permanently, we found that C. difficile producing either one or both toxins showed cytotoxic activity in vitro that translated directly into virulence in vivo. Furthermore, by constructing the first ever double-mutant strain of C. difficile, in which both toxin genes were inactivated, we were able to completely attenuate virulence. Our findings re-establish the importance of both toxin A and toxin B and highlight the need to continue to consider both toxins in the development of diagnostic tests and effective countermeasures against C. difficile.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
£199.00 per year
only £3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Poutanen, S. M. & Simor, A. E. Clostridium difficile-associated diarrhea in adults. Can. Med. Assoc. J. 171, 51–58 (2004)
Elliott, B., Chang, B. J., Golledge, C. L. & Riley, T. V. Clostridium difficile-associated diarrhoea. Intern. Med. J. 37, 561–568 (2007)
Lyerly, D. M., Saum, K. E., MacDonald, D. K. & Wilkins, T. D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect. Immun. 47, 349–352 (1985)
Lyras, D. et al. Toxin B is essential for virulence of Clostridium difficile . Nature 458, 1176–1179 (2009)
Heap, J. T., Pennington, O. J., Cartman, S. T., Carter, G. P. & Minton, N. P. The ClosTron: a universal gene knock-out system for the genus Clostridium . J. Microbiol. Methods 70, 452–464 (2007)
Heap, J. T. et al. The ClosTron: Mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 80, 49–55 (2010)
Just, I. & Gerhard, R. Large clostridial cytotoxins. Rev. Physiol. Biochem. Pharmacol. 152, 23–47 (2004)
Hussain, H. A., Roberts, A. P. & Mullany, P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Δerm) and demonstration that the conjugative transposon Tn916ΔE enters the genome of this strain at multiple sites. J. Med. Microbiol. 54, 137–141 (2005)
Torres, J., Camorlinga-Ponce, M. & Munoz, O. Sensitivity in culture of epithelial cells from rhesus monkey kidney and human colon carcinoma to toxins A and B from Clostridium difficile . Toxicon 30, 419–426 (1992)
Sebaihia, M. et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nature Genet. 38, 779–786 (2006)
Hachler, H., Berger-Bachi, B. & Kayser, F. H. Genetic characterization of a Clostridium difficile erythromycin-clindamycin resistance determinant that is transferable to Staphylococcus aureus . Antimicrob. Agents Chemother. 31, 1039–1045 (1987)
O’Connor, J. R. et al. Construction and analysis of chromosomal Clostridium difficile mutants. Mol. Microbiol. 61, 1335–1351 (2006)
Kim, P. H., Iaconis, J. P. & Rolfe, R. D. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters. Infect. Immun. 55, 2984–2992 (1987)
Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247–263 (2005)
Du, T. & Alfa, M. J. Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. Can. J. Infect. Dis. 15, 83–88 (2004)
Chaves-Olarte, E. et al. R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile . J. Biol. Chem. 278, 7956–7963 (2003)
Torres, J. F. Purification and characterisation of toxin B from a strain of Clostridium difficile that does not produce toxin A. J. Med. Microbiol. 35, 40–44 (1991)
Alfa, M. J. et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38, 2706–2714 (2000)
Stabler, R. A., Dawson, L. F., Phua, L. T. & Wren, B. W. Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J. Med. Microbiol. 57, 771–775 (2008)
Drudy, D., Fanning, S. & Kyne, L. Toxin A-negative, toxin B-positive Clostridium difficile . Int. J. Infect. Dis. 11, 5–10 (2007)
Drudy, D., Harnedy, N., Fanning, S., Hannan, M. & Kyne, L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile . Infect. Control Hosp. Epidemiol. 28, 932–940 (2007)
Heap, J. T., Pennington, O. J., Cartman, S. T. & Minton, N. P. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 78, 79–85 (2009)
Williams, D. R., Young, D. I. & Young, M. Conjugative plasmid transfer from Escherichia coli to Clostridium acetobutylicum . J. Gen. Microbiol. 136, 819–826 (1990)
Sorg, J. A. & Sonenshein, A. L. Bile salts and glycine as cogerminants for Clostridium difficile spores. J. Bacteriol. 190, 2505–2512 (2008)
Cartman, S. T. & Minton, N. P. A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile . Appl. Environ. Microbiol. 76, 1103–1109 (2010)
Sambrook, J. & Russell, D. W. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 2001)
Acknowledgements
S.A.K., S.T.C., A.C. and N.P.M. acknowledge the financial support of the UK Medical Research Council (G0601176). Support for M.L.K. was provided by the European Union (HEALTH-F3-2008-223585) and for J.T.H. by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F003390/1). We thank C. von-Eichel Streiber for supplying the neutralizing antibody serums and Y. Mahida for the Vero cells. We are also grateful to A. Olling and R. Gerhard for methodological advice on western blots.
Author information
Authors and Affiliations
Contributions
The study was conceived by N.P.M. and designed by S.A.K., S.T.C. and J.T.H. Construction of mutants and in vitro characterization was carried out by S.A.K. In vivo work was carried out by S.T.C., M.L.K. and A.C. Analysis of data was carried out by S.A.K. and M.L.K. with assistance from S.T.C. and J.T.H. The manuscript was written by S.A.K. and S.T.C. with critical input from all other authors. Funding for the study was sourced by N.P.M. and A.C.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Figures
This file contains Supplementary Figure 1 with a legend. (PDF 669 kb)
Rights and permissions
About this article
Cite this article
Kuehne, S., Cartman, S., Heap, J. et al. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711–713 (2010). https://doi.org/10.1038/nature09397
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature09397